#novo-nordisk

[ follow ]
#weight-loss-drugs
Startup companies
fromFast Company
1 day ago

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.
fromFuturism
7 months ago
Wellness

Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds

Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.
from24/7 Wall St.
2 weeks ago
Wearables

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Ozempic's explosive sales growth reflects its successful transition from a diabetes treatment to a leading weight loss drug.
fromFuturism
2 weeks ago
NYC startup

Novo Nordisk Is Getting Absolutely Destroyed

Novo Nordisk's stock has fallen sharply after Eli Lilly announced effective trial results for an oral weight-loss pill.
fromFast Company
4 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

CagriSema failed to meet weight loss expectations in trials, causing significant stock decline for Novo Nordisk.
from24/7 Wall St.
1 month ago
NYC startup

Novo Nordisk (NVO) Price Prediction and Forecast 2025-2030 (March 2025)

Ozempic's sales surge has significantly boosted Novo Nordisk's market value, reflecting the drug's unexpected profitability as a weight-loss treatment.
Startup companies
fromFast Company
1 day ago

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

Novo Nordisk's market outlook improves with FDA's ban on GLP-1 drug copycats.
Despite profit forecasts lowering, investor sentiment towards Novo Nordisk remains optimistic.
fromFuturism
7 months ago
Wellness

Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds

Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.
from24/7 Wall St.
2 weeks ago
Wearables

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Ozempic's explosive sales growth reflects its successful transition from a diabetes treatment to a leading weight loss drug.
fromFuturism
2 weeks ago
NYC startup

Novo Nordisk Is Getting Absolutely Destroyed

Novo Nordisk's stock has fallen sharply after Eli Lilly announced effective trial results for an oral weight-loss pill.
fromFast Company
4 months ago
Medicine

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

CagriSema failed to meet weight loss expectations in trials, causing significant stock decline for Novo Nordisk.
from24/7 Wall St.
1 month ago
NYC startup

Novo Nordisk (NVO) Price Prediction and Forecast 2025-2030 (March 2025)

Ozempic's sales surge has significantly boosted Novo Nordisk's market value, reflecting the drug's unexpected profitability as a weight-loss treatment.
more#weight-loss-drugs
#fda
fromBusiness Matters
1 day ago
NYC startup

Novo Nordisk cuts forecasts as Ozempic and Wegovy sales hit by US copycat versions

Novo Nordisk has lowered its revenue and profit forecasts due to sales pressure from unauthorized compounded GLP-1 drugs.
Wegovy is expected to see growth rebound after the FDA ban on compounded versions.
fromBusiness Matters
1 day ago
NYC startup

Novo Nordisk cuts forecasts as Ozempic and Wegovy sales hit by US copycat versions

Novo Nordisk has lowered its revenue and profit forecasts due to sales pressure from unauthorized compounded GLP-1 drugs.
Wegovy is expected to see growth rebound after the FDA ban on compounded versions.
more#fda
#sap
fromTNW | Ecosystems
1 month ago
European startups

SAP becomes Europe's biggest company, ASML holds fourth place

SAP's recent stock surge has positioned it as Europe's most valuable company, surpassing Novo Nordisk in market capitalization.
fromTechzine Global
1 month ago
European startups

SAP is now the most valuable European public company

SAP has become Europe's most valuable company, surpassing Novo Nordisk due to strong investor confidence and growth in cloud-based services.
fromTechzine Global
1 month ago
European startups

SAP is now the most valuable European public company

SAP has become Europe's most valuable company, surpassing Novo Nordisk due to strong investor confidence and growth in cloud-based services.
more#sap
#wegovy
NYC startup
fromwww.nytimes.com
2 months ago

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Novo Nordisk reduces Wegovy's price to $499 for cash-paying patients, but government-insured patients still face high costs.
fromABC7 San Francisco
7 months ago
Left-wing politics

'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing

The U.S. pays significantly higher prices for Ozempic and Wegovy compared to other countries, prompting scrutiny from Senate leaders.
fromFortune Well
10 months ago
OMG science

Ozempic and Wegovy linked to rare vision loss

Novo Nordisk's drugs Ozempic and Wegovy linked to higher risk of vision loss.
fromwww.theguardian.com
3 months ago
Miscellaneous

Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar

Novo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.
Medicine
fromFuturism
8 months ago

Woman Says Her Colon Had to Be Removed After Taking Ozempic

A woman is suing Novo Nordisk after losing her colon due to complications she claims were caused by their weight loss and diabetes medications.
Medicine
fromFortune
7 months ago

Bernie Sanders grills Ozempic maker over high prices

Novo Nordisk CEO faced scrutiny in Congress over drug pricing and its moral implications for patients, especially in relation to high prices and access to medication.
NYC startup
fromwww.nytimes.com
2 months ago

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Novo Nordisk reduces Wegovy's price to $499 for cash-paying patients, but government-insured patients still face high costs.
Left-wing politics
fromABC7 San Francisco
7 months ago

'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing

The U.S. pays significantly higher prices for Ozempic and Wegovy compared to other countries, prompting scrutiny from Senate leaders.
fromwww.theguardian.com
3 months ago
Miscellaneous

Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar

Novo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.
fromFuturism
8 months ago
Medicine

Woman Says Her Colon Had to Be Removed After Taking Ozempic

A woman is suing Novo Nordisk after losing her colon due to complications she claims were caused by their weight loss and diabetes medications.
fromFortune
7 months ago
Medicine

Bernie Sanders grills Ozempic maker over high prices

Novo Nordisk CEO faced scrutiny in Congress over drug pricing and its moral implications for patients, especially in relation to high prices and access to medication.
more#wegovy
Digital life
fromwww.nytimes.com
3 months ago

Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

Novo Nordisk reported strong earnings in 2024 but expects slower sales growth in 2025 due to competition.
The company’s share price has fallen dramatically amid uncertainties in the obesity drug market.
#ozempic
Miscellaneous
fromFuturism
5 months ago

Dr. Oz Will Have a Fascinating Conflict of Interest Running Medicare: Ozempic

Mehmet Oz's potential role in leading Medicare raises concerns due to his past connections with Novo Nordisk, makers of Ozempic.
fromFortune Well
7 months ago
Medicine

Forget the shot. A weight loss pill saw promising results in Phase 1 testing

Amycretin, a new pill, could offer a convenient weight loss alternative to Ozempic, showing potential for significant weight loss within three months.
fromFortune
7 months ago
Privacy professionals

Ozempic 'very likely' to have price slashed

Ozempic is expected to be included in upcoming negotiations for price reductions under the US government's new drug pricing policies.
Miscellaneous
fromFuturism
5 months ago

Dr. Oz Will Have a Fascinating Conflict of Interest Running Medicare: Ozempic

Mehmet Oz's potential role in leading Medicare raises concerns due to his past connections with Novo Nordisk, makers of Ozempic.
fromFortune Well
7 months ago
Medicine

Forget the shot. A weight loss pill saw promising results in Phase 1 testing

Amycretin, a new pill, could offer a convenient weight loss alternative to Ozempic, showing potential for significant weight loss within three months.
fromFortune
7 months ago
Privacy professionals

Ozempic 'very likely' to have price slashed

Ozempic is expected to be included in upcoming negotiations for price reductions under the US government's new drug pricing policies.
more#ozempic
fromBusiness Insider
4 months ago
Miscellaneous

I'm the Danish scientist who pioneered injectable drugs like Ozempic. Here are my 3 tips for inventing blockbuster products.

Lotte Bjerre Knudsen's research was pivotal in transforming short-acting GLP-1 hormones into successful long-acting diabetes treatments like Ozempic.
fromFortune Europe
7 months ago
Left-wing politics

Novo Nordisk CEO takes aim at U.S. health system in Ozempic testimony

Novo Nordisk's weight loss drugs are effective but criticized for their high costs and accessibility issues in the U.S.
Medicine
fromFuturism
7 months ago

Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects

Novo Nordisk's new weight loss drug monlunabant shows promising results but raises concerns due to increased risk of psychiatric side effects compared to placebo.
Medicine
fromBusiness Insider
7 months ago

The next big market for weight-loss drugs: children

Novo Nordisk's Saxenda can significantly reduce children's BMI, showing potential for FDA approval in a market with currently no approved obesity medications for children.
[ Load more ]